U.S. Professional Services Stock News

NYSE:XYZ
NYSE:XYZDiversified Financial

US Stock Market Today: S&P 500 Futures Surge as Investors Eye Easing Rate Hike Pressure

The Morning Bull - US Market Morning Update Thursday, Nov, 20 2025 US stock futures are pointing higher this morning, with contracts linked to the major indexes rising more than 1% before the opening bell. Two stories are grabbing attention. First, the US economy added just 50,000 jobs in September, much less than usual but still showing some hiring. At the same time, average mortgage rates nudged up to 6.37%, and mortgage applications slumped by over 5%, making it harder for people to buy...
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

Does CEO Frost’s Share Purchase Offset Concerns About OPKO Health’s (OPK) Sales Outlook?

Phillip Frost, CEO and Chairman of OPKO Health, and Frost Gamma Investments Trust recently acquired US$737,747 worth of OPKO Health shares, significantly increasing Frost's ownership both directly and indirectly. This activity coincided with a downgrade from Jefferies, who shifted their rating from Buy to Hold due to concerns over flat sales guidance for Ngenla, a growth hormone product developed with Pfizer. To assess how insider buying by the CEO could influence OPKO Health’s outlook,...
NasdaqGM:VNDA
NasdaqGM:VNDABiotechs

Vanda Pharmaceuticals (VNDA): Valuation Focus After Positive Tradipitant Trial Results and Regulatory Progress

Vanda Pharmaceuticals (VNDA) recently shared clinical trial results showing its drug tradipitant delivered clear benefits for patients experiencing nausea and vomiting from GLP-1 therapy with Wegovy. The trial met both key efficacy measures and reported no new safety concerns. See our latest analysis for Vanda Pharmaceuticals. Alongside the latest clinical win, Vanda’s share price recently surged 18% over the past week as investors digested upbeat trial news. However, momentum has been mixed;...
NYSE:MMS
NYSE:MMSProfessional Services

Is Maximus a Bargain After Its Latest Government Services Expansion News?

Wondering whether Maximus is a bargain or overvalued right now? If you are curious about the true worth of this stock, you are not alone. The share price has dipped 3.5% over the past week and is down 10.7% in the last month, but is still up 2.6% year-to-date. This gives mixed signals about investor sentiment and potential risk or growth. Maximus has recently been in the spotlight following several key contract announcements and expansion news. These updates related to government services...
NasdaqGM:LFMD
NasdaqGM:LFMDHealthcare Services

LifeMD (LFMD) Valuation in Focus After Earnings Miss, Guidance Cut, and WorkSimpli Divestiture

LifeMD (LFMD) turned heads after releasing a mix of disappointing third-quarter earnings and a downward revision to its 2025 revenue and EBITDA forecasts, following its decision to divest its stake in WorkSimpli. See our latest analysis for LifeMD. LifeMD’s share price has tumbled in recent weeks, with a 1-day return of -2.44% capping off a much steeper 7-day decline of -21.3% as the market reacted to the lowered 2025 outlook and WorkSimpli divestiture. The one-year total shareholder return...